揭示了刺激性肠综合征的复杂性
Duygu Kirkik1,2, Sevgi Kalkanli Tas1
1Department of Immunology, University of Health Sciences, Hamidiye Medicine Faculty, Istanbul 34668, Türkiye.
World journal of gastroenterology
|November 29, 2024
概括
刺激性肠综合征 (IBS) 涉及复杂的肠-大脑轴,微生物群和炎症相互作用. 了解这些神经内分泌和微生物失衡是有效的IBS治疗的关键.
科学领域:
- 胃肠病学 胃肠病学
- 神经内分泌学神经内分泌学
- 微生物学 微生物学
背景情况:
- 刺激性肠综合征 (IBS) 是一种慢性胃肠疾病,其机制复杂且不太清楚.
- 肠-大脑轴,肠道微生物群和炎症反应越来越被认为是IBS病理生理学的关键因素.
- 神经内分泌失衡,如皮质醇和血清激素的改变,与IBS症状严重程度有关.
研究的目的:
- 探索神经内分泌系统,肠道微生物群和IBS炎症之间的复杂关系.
- 突出肠-大脑轴在调节肠胃功能和IBS患者应激反应中的作用.
- 为了强调肠道失调对IBS神经内分泌和炎症通路的影响.
主要方法:
- 审查关于神经内分泌轴,肠道微生物群和IBS炎症标志物的当前研究.
- 对研究肠-大脑轴通信及其在IBS中的失调的研究进行分析.
- 检查肠道失调症在恶化IBS症状和相关反应中的作用.
主要成果:
- 神经内分泌轴的调节失调,由皮质醇和血清激素的升高证明,与IBS症状严重程度的增加有关.
- 肠道微生物群的失调破坏了正常的肠道功能,并强化了IBS中的神经内分泌和炎症反应.
- 肠-大脑轴内的双向通信对平衡至关重要,其中断有助于IBS.
结论:
- 神经内分泌失衡和肠道微生物群失调是IBS病理生理学的重要贡献者.
- 对肠-大脑轴的全面理解对于开发有针对性和个性化的IBS疗法至关重要.
- 未来的研究应该集中在压力,神经内分泌功能,微生物群和IBS管理中的炎症之间的相互作用上.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
247
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
247
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
141
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
141
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
169
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
169
01:17Chronic Bowel Disorders: Introduction
388
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
388
01:17Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
317
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
317